Additionally, paste this code immediately after the opening tag:


ACTIVE FLUIDICS™

Helps provide superior chamber stability1
with less surge and a more consistent IOP.2

LOG IN TO ORDER

Use your Online Ordering ID to access your account.

Learn more.

DECREASE SURGE, INCREASE STABILITY

Through its Active Fluidics™ technology, the Centurion® Vision System is designed to significantly reduce occlusion break surge.

Average Volume Trace3

Val Limit=600 mmHg, IOP Setpoint=55 mmHg

Charts showing that Active Fluidics™ technology results in reduced occlusion break surge and more consistent IOP compared with gravity fluidics.

Active Fluidics™ Technology results in reduced occlusion break surge and
more consistent IOP compared with gravity fluidics.

Observed surge area for Centurion® is 80 percent less than INFINITI® at 400 mmHg.1 Active Fluidics™ technology results in reduced occlusion break surge and more consistent IOP compared with gravity fluidics.

Occlusion Break Surge Across Vacuum Limit Range1

Chart showing that Centurion<sup>®</sup> has less surge at any tested vacuum level vs. Signature.

Centurion® has less surge at any tested vacuum level vs. Signature.*

Track Your Procedure with Centurion®

The Centurion<sup>®</sup> Vision System GUI showing high chamber stability. It improves chamber stability compared to gravity and pressurized fluidics systems.

The Centurion® Vision System improves chamber stability compared to gravity and pressurized fluidics systems.2

*Trademarks are the property of their respective owners.

Related Content

CENTURION® ENERGY DELIVERY

CENTURION® ENERGY DELIVERY

Harmonizing OZil® Torsional Phaco
delivery with increased fluidic control
to maximize performance4

INTREPID® INTEGRATION

INTREPID® INTEGRATION

Designed to enhance surgeon
control during IOL insertions with
a micro-incisional portfolio

  1. Sharif-Kashani P, Fanney D, Injev V. Comparison of occlusion break responses and vacuum rise times of phacoemulsification systems. BMC Ophthalmol. 2014;14:96.
  2. Nicoli CM, Dimalanta R, Miller K. Experimental anterior chamber maintenance in active versus passive phacoemulsification fluidics systems. J Cataract Refract Surg. 2016;42(1):157-162.
  3. Engineering Study Report for Occlusion Break Surge Traces of Centurion®, INFINTI® Vision Systems. Alcon internal technical report: TDOC-954-3160-034. Effective date 28 Oct 2013.
  4. Solomon K, Lorente R, Cionni R, Fanney D. Prospective, randomized clinical study using a new phaco system with intraocular system target pressure control. ASCRS-ASOA Symposium and Congress; April 25-29, 2014; Boston, USA.

Video Resources

View Case, testimonial and product videos

VIEW IMPORTANT PRODUCT INFORMATION FOR:

CENTURION® VISION SYSTEM IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to sale by, or on the order of, a physician.

As part of a properly maintained surgical environment, it is recommended that a backup IOL Injector be made available in the event the AutoSert® IOL Injector Handpiece does not perform as expected.

INDICATION: The Centurion® Vision System is indicated for emulsification, separation, irrigation, and aspiration of cataracts, residual cortical material and lens epithelial cells, vitreous aspiration and cutting associated with anterior vitrectomy, bipolar coagulation, and intraocular lens injection. The AutoSert® IOL Injector Handpiece is intended to deliver qualified AcrySof® intraocular lenses into the eye following cataract removal.

The AutoSert® IOL Injector Handpiece achieves the functionality of injection of intraocular lenses. The AutoSert® IOL Injector Handpiece is indicated for use with the AcrySof® lenses SN6OWF, SN6AD1, SN6AT3 through SN6AT9, as well as approved AcrySof® lenses that are specifically indicated for use with this inserter, as indicated in the approved labeling of those lenses.

WARNINGS: Appropriate use of Centurion® Vision System parameters and accessories is important for successful procedures. Use of low vacuum limits, low flow rates, low bottle heights, high power settings, extended power usage, power usage during occlusion conditions (beeping tones), failure to sufficiently aspirate viscoelastic prior to using power, excessively tight incisions, and combinations of the above actions may result in significant temperature increases at incision site and inside the eye, and lead to severe thermal eye tissue damage.

Good clinical practice dictates the testing for adequate irrigation and aspiration flow prior to entering the eye. Ensure that tubings are not occluded or pinched during any phase of operation.

The consumables used in conjunction with ALCON® instrument products constitute a complete surgical system. Use of consumables and handpieces other than those manufactured by Alcon may affect system performance and create potential hazards.

AEs/COMPLICATIONS: Inadvertent actuation of Prime or Tune while a handpiece is in the eye can create a hazardous condition that may result in patient injury. During any ultrasonic procedure, metal particles may result from inadvertent touching of the ultrasonic tip with a second instrument. Another potential source of metal particles resulting from any ultrasonic handpiece may be the result of ultrasonic energy causing micro abrasion of the ultrasonic tip.

ATTENTION: Refer to the Directions for Use and Operator’s Manual for a complete listing of indications, warnings, cautions and notes.